It is well known that high density lipoprotein (HDL) binds bacterial lipopolysaccharide (LPS) and neutralizes its toxicity. The aim of this work was to study changes in the apolipoprotein (apo) AI structure after its interaction with LPS as well as to determine the protein domain involved in that interaction. The presented data indicate that LPS does not lead to major changes in the structure of apoAI, judging from Trp fluorescence spectra. However, analysis of denaturation behavior and binding of ANS show that LPS induces a loosened protein conformation. Further evidence for an apoAI—LPS specific interaction was obtained by incubation of the protein with 125I-ASD-LPS. The results show that multiple regions of the protein were able to interact with LPS, according to its amphiphatic nature. Finally, the contribution of the purified C-terminal fragment of the protein in the endotoxin neutralization was evaluated in comparison with the effect of apoAI. In both cases, the same decrease in tumor necrosis factor-α released was observed. This result suggests that the C-terminal half of apoAI is the main domain responsible of the neutralization effect of this protein. Our data may provide innovative pharmacological tools in endotoxin neutralization therapies.
Wu A., Hinds CJ, Thiemermann C.High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock2004; 21: 210-221.
2.
van Leeuwen HJ, Heezius EC, Dallinga GM et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med2003; 31: 1359-1366.
3.
Liao XL, Ma J., Lou B. et al. Alteration of the components in serum high density lipoprotein during the acute phase reaction induced by lipopolysaccharide. Fudan Univ J Med Sci2004; 31: 469-472.
4.
Van Lenten BJ , Hama SY, de Beer FC et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest1995; 96: 2758-2767.
5.
Parker TS, Levine DM, Chang JC et al. Reconstituted high-density lipoprotein neutralizes Gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun1995; 63: 253-258.
6.
Gordon BR, Parker TS, Levine DM et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med1996; 24: 584-589.
7.
Massamiri T. , Tobias PS, Curtiss LKStructural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res1997 ; 38: 516-525.
8.
Park CT, Wright SDPlasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins . J Biol Chem1996; 271: 18054-18060.
9.
Emancipator K., Csako G., Elin RJ In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun1992; 60: 596-601.
10.
Yan Y., Li Y., Lou B. et al. Beneficial effects of ApoA-I on LPSinduced acute lung injury and endotoxemia in mice. Life Sci2006; 79: 210-215.
11.
Ma XL, Liao B., Wu MPRole of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sinica2004; 36: 419-424.
12.
Tricerri A. , Corsico B., Toledo JD et al. Conformation of apolipoprotein AI in reconstituted lipoprotein particles and particle-membrane interaction: effect of cholesterol. Biochim Biophys Acta1998; 1391: 67-78.
13.
Aurell C., Wistrom A.Critical aggregation concentrations of Gram-negative bacterial lipopolysaccharides (LPS). Biochem Biophys Res Commun1998; 253: 119-123.
14.
Valpuesta J. , Goñi F., Macarulla J.Tryptophan fluorescence of mitochondrial complex III reconstituted in phosphatidylcholine bilayers. Arch Biochem Biophys1987; 257: 285-292.
15.
Ohnishi M., Kawagishi T.Stopped-flow studies on the chemical modification with N-bromosuccinimide of model compounds of tryptophan residues. J Biochem1980; 87: 273-279.
16.
Stryer L.The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of nonpolar binding sites. J Mol Biol1965; 13: 482-495.
17.
Lackowicz J.Principles of Fluorescence Spectroscopy. New York: Plenum, 1984.
18.
Schmid F.Spectral methods of characterizing protein conformation and conformational changes. In: Creighton TE. (ed) Protein Structure: A Practical Approach. Oxford: IRL, 1989. p 251.
19.
Chen Y., Yang J., Martinez H.Determination of the secondary structures of proteins by circular dichroism and optical rotary dispersion. Biochemistry1972; 11: 4120-4131.
20.
Wollenweber HW, Morrison DCSynthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J Biol Chem1985; 260: 15068-15074.
21.
Ulevitch RJThe preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry1978; 15: 157-164.
22.
Karkhanis Y. , Zeltner J., Jackson J. et al. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem1978; 85: 595-601.
23.
Laemmli U.Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature1970; 227: 680-685.
24.
Schägger H., von Jagow G.Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem1987; 166: 368-379.
25.
Hager D., Burgess R.Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal Biochem1980; 109: 76-86.
26.
Ohhashi T., Moritani C., Andoh H. et al. Preparative high-yield electroelution of proteins after separation by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and its application to analysis of amino acid sequences and to raise antibodies. J Chromatogr1991; 585: 153-159.
27.
Lowry O., Rosebrough N., Farr A. et al. Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193: 265-275.
28.
Burstein EA, Vedenkina NS, Ivkova MNFluorescence and the location of tryptophan residues in protein molecules . Photochem Photobiol1973; 18: 263-279.
29.
Pace C.Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol1986; 131: 266-280.
30.
Myers J., Pace C., Scholtz J.Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci1995; 4: 2138-2148.
31.
Atkinson D., Small DMRecombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem1986; 15: 403-456.
32.
Dalton M., Swaney J.Structural and functional domains of apolipoprotein AI within high density lipoproteins. J Biol Chem1993; 268: 19274-19283.
33.
Brewer Jr HB , Fairwell T., LaRue A. et al. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun1978; 80: 623-630.
34.
Davidson WS , Arnvig-McGuire K., Kennedy A. et al. Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. Biochemistry1999; 38: 14387-14395.
35.
Gursky O., Atkinson D.Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci USA1996; 93: 2991-1995.
36.
Roberts LM, Ray MJ, Shih TW et al. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human Apo A-I . Biochemistry1997; 36: 7615-7624.
37.
Zhu H., Atkinson D.Conformation and lipid binding of a C-terminal 198-243. peptide of human apolipoprotein A-I. Biochemistry2007; 46: 1624-1634.
38.
Palgunachari M., Mishra V., Lund-Katz S. et al. Only the two end helixes of eight tandem amphipathic helical domains of human apoAI have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol1996; 16: 328-338.
39.
Segrest J., Garber D., Brouillette C. et al. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem1994; 45: 303-369.
40.
Segrest JP, Jones MK, De Loof H. et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res1992; 33: 141-166.
Segrest J., De Loof H., Dohlman J. et al. Amphipathic helix motif: classes and properties. Proteins1990; 8: 103-117.
43.
Ji Y., Jonas A.Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J Biol Chem1995; 270: 11290-11297.
44.
Morrison J. , Fidge N., Tozuka M.Determination of the structural domain of apoAI recognized by high density lipoprotein receptors. J Biol Chem1991; 266: 18780-18785.
45.
Córsico B., Toledo J., Garda H.Evidence for a central apolipoprotein AI domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. J Biol Chem2001; 276: 16978-16985.
